Several posts have been moved from this thread:
Ampligen - Hemispherx Biopharma re ME/CFS
not relating to ME but Covid-19
AIM ImmunoTech inks deal to research vaping device as a vehicle for Ampligen to treat coronavirus...
published in frontiers in Medicine - Family Medicine and Primary Care
Results: The overall response rate by Fatigue score was 55.0% (22 of 40 patients). Fatigue score and other outcome variables showed significant improvements compared to baseline. The SF-36 Physical Function score increased...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.